Financials
- Market Capitalization 38.53 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.17
市销率
-7.22
每股股息
49.5
股息收益率 %
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4314 | SCYX SCYNEXIS, Inc. - Common Stock | 4.75 USD | -3.65% | +1.50% | +15.85% | +533.33% | 47.17 M USD | ||
| 4334 | CPHI China Pharma Holdings, Inc. Common Stock | 1.13 USD | +85.25% | +59.15% | +48.68% | +70.93% | 45.79 M USD | ||
| 4425 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.75 USD | +2.74% | -2.60% | -6.25% | -69.26% | 35.54 M USD | ||
| 4553 | AYTU Aytu BioPharma, Inc. - Common Stock | 2.22 USD | +0.91% | +1.83% | +0.91% | +2.30% | 23.83 M USD |